QLT sets up US sales force for Visudyne
This article was originally published in Scrip
Executive Summary
QLT has established a new US subsidiary, QLT Ophthalmics, to take on US sales and marketing of its drug and laser therapy for wet age-related macular degeneration, Visudyne (verteporfin for injection).